亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Efficacy and Tolerability of Controlled-Release and Immediate-Release Paroxetine in the Treatment of Depression

帕罗西汀 耐受性 安慰剂 恶心 医学 心理学 重性抑郁障碍 不利影响 抗抑郁药 中止 精神科 内科学 麻醉 焦虑 心情 替代医学 病理
作者
Robert N. Golden,Charles B. Nemeroff,P. McSorley,Cornelius D. Pitts,Evemie Dubé
出处
期刊:The Journal of Clinical Psychiatry [Physicians Postgraduate Press, Inc.]
卷期号:63 (7): 577-584 被引量:92
标识
DOI:10.4088/jcp.v63n0707
摘要

Antidepressant efficacy may be compromised by early discontinuation of treatment secondary to common, treatment-emergent side effects, including nausea, agitation, and somnolence. Paroxetine controlled-release (CR) was developed to improve general tolerability and, in particular, gastrointestinal tolerability.To determine the antidepressant efficacy and tolerability of paroxetine CR in adult patients 18 to 65 years of age with DSM-IV major depressive disorder.Paroxetine CR (25-62.5 mg/day; N = 212) and paroxetine immediate-release (IR; 20-50 mg/day; N = 217) were compared with placebo (N = 211) in the pooled dataset from 2 identical, double-blind, 12-week clinical trials.Both paroxetine CR and paroxetine IR exhibited efficacy in major depressive disorder as assessed by the reduction in 17-item Hamilton Rating Scale for Depression total score compared with placebo. Moreover, depressed mood and psychic anxiety symptoms improved as early as treatment week 1 in the paroxetine CR group compared with the placebo group. After 6 weeks of treatment, response and remission rates were 41.5% and 20.5% for placebo, 52.8% and 29.6% for paroxetine IR, and 58.9% and 34.4% for paroxetine CR, respectively. After 12 weeks of treatment, response and remission rates were 61.2% and 44.0% for placebo, 72.9% and 52.5% for paroxetine IR, and 73.7% and 56.2% for paroxetine CR, respectively. Rates of nausea were significantly lower for paroxetine CR (14%) than for paroxetine IR (23%; p < or = .05) during week 1. Rates of dropout due to adverse events were comparable between paroxetine CR and placebo, while significantly (p = .0008) more patients treated with paroxetine IR withdrew from the study prematurely compared with those treated with placebo.Paroxetine CR is an effective and well-tolerated antidepressant exhibiting symptomatic improvement as early as week 1. Paroxetine CR is associated with low rates of early-onset nausea and dropout rates due to adverse events comparable to those of placebo. The clinical improvement seen with paroxetine CR, coupled with its favorable adverse event profile, suggests a benefit for therapeutic outcome with paroxetine CR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
陈淋完成签到,获得积分10
6秒前
小巧的孤丹完成签到,获得积分10
10秒前
null的应助被科研通管家采纳,获得10
15秒前
大模型的应助被科研通管家采纳,获得10
16秒前
16秒前
所所的应助被科研通管家采纳,获得10
16秒前
16秒前
null的应助被科研通管家采纳,获得10
16秒前
90min完成签到 ,获得积分10
31秒前
科研通AI6.4的应助被盐水菠萝采纳,获得10
31秒前
CipherSage的应助被somehgo采纳,获得10
45秒前
47秒前
华仔的应助被开心超人采纳,获得10
49秒前
风中的晓兰完成签到,获得积分10
59秒前
somehgo给somehgo的求助进行了留言
1分钟前
1分钟前
科研通AI6.3的应助被AdamReed300采纳,获得40
1分钟前
林楚棋发布了新的文献求助10
1分钟前
1分钟前
1分钟前
我与我周旋久完成签到,获得积分10
1分钟前
AdamReed300发布了新的文献求助40
1分钟前
xxx完成签到 ,获得积分10
1分钟前
科研通AI6.3的应助被dcm采纳,获得10
1分钟前
1分钟前
1分钟前
somehgo发布了新的文献求助10
1分钟前
科科科科发布了新的文献求助10
1分钟前
1分钟前
健忘青枫完成签到,获得积分10
1分钟前
1分钟前
高高的飞机完成签到,获得积分10
1分钟前
somehgo完成签到,获得积分10
2分钟前
龙龙发布了新的文献求助10
2分钟前
2分钟前
null的应助被科研通管家采纳,获得10
2分钟前
null的应助被科研通管家采纳,获得10
2分钟前
欣喜寒烟发布了新的文献求助10
2分钟前
一颗白桃桃完成签到 ,获得积分10
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173069
求助须知:如何正确求助?哪些是违规求助? 9565519
关于积分的说明 21780335
捐赠科研通 7765068
什么是DOI,文献DOI怎么找? 3431528
关于科研通互助平台的介绍 2555609
邀请新用户注册赠送积分活动 2476668